Johnson & Johnson MedTech has onboarded Qure.ai as a strategic partner to enhance early detection of lung cancer in India. This collaboration brings together cutting-edge […]
Tag: Qure.ai
Qure.ai secures $65 million Series D funding to expand global AI reach
Qure.ai recently closed a $65 million Series D funding round. This round was led by Lightspeed and 360 ONE Asset, with participation from Merck Global […]
USFDA grants breakthrough device designation to Qure.ai’s AI-powered TB solution
The United States Food and Drug Administration (USFDA) has granted breakthrough device designation to Qure.ai’s AI-powered Tuberculosis (TB) solution, qSpot-TB, a company statement informed. The […]
USFDA approves Qure.ai’s AI-driven chest X-ray solution
The United States Food and Drug Administration (USFDA) has approved Qure.ai’s Artificial Intelligence (AI)-enabled solution for chest X-ray. The solution based on qXR-LN uses AI […]